The FDA is expected to decide on treatments for acute myeloid leukemia, chronic rhinosinusitis with nasal polyps, lupus nephritis, pediatric myopia, and small-cell lung cancer.

The American Academy of Family Physicians has released its fall immunization recommendations for COVID-19, RSV, and influenza.

The WHO added 20 new medicines to the EML, including GLP-1 RAs, 15 to the EMLc, and new indications for 7 existing medicines.

Among patients with IBD, HLA-B27 positivity and higher UC disease activity were associated with an increased risk for SpA.

Higher risks for spontaneous pregnancy loss and congenital anomalies were seen in association with exposure to preconception CT.

Patients with isolated PMR or GCA in Norway had all-cause mortality rates that were similar to members of the general population.

Significantly higher risk for psoriasis was seen with poor cardiovascular-kidney-metabolic health, especially in those with genetic risk.

The 100-μg dose and the 200-μg dose groups has significantly lower Hamilton Anxiety Rating Scale scores at week 4. HealthDay News — A single dose of a pharmaceutical formulation of LSD provides ...

Despite proven efficacy of osteoporosis medications, patients turn to dietary supplements marketed for bone health that lack ...

Ingredients not on the green list for GLP-1 drugs in compliance with FDA standards are subject to detention without examination at the border.

Inflammatory bowel disease (IBD) and autoimmune liver disease (AILD) prevalence are significantly correlated, according to a study in the Journal of Gastroenterology and Hepatology. The findings are ...

An analysis of postmarketing safety data for anifrolumab in SLE found AEs that were not previously listed on labeling materials, including dyspnea, pyrexia, and vomiting.